C75, a synthetic inhibitor of FAS (fatty acid synthase), has both anti-tumour and anti-obesity properties. In this study we provide a detailed kinetic characterization of the mechanism of in vitro inhibition of rat liver FAS. At room temperature, C75 is a competitive irreversible inhibitor of the overall reaction with regard to all three substrates, i.e. acetyl-CoA, malonyl-CoA and NADPH, exhibiting pseudo-first-order kinetics of the complexing type, i.e. a weak non-covalent enzyme-inhibitor complex is formed before irreversible enzyme modification. C75 is a relatively inefficient inactivator of FAS, with a maximal rate of inactivation of 1 min
INTRODUCTION
A single, homodimeric, multifunctional FAS (fatty acid synthase; EC 2.3.1.38) is primarily responsible for the endogenous biosynthesis of palmitate in mammals [1] . It utilizes acetyl-CoA, malonyl-CoA and NADPH in a stepwise and sequential manner to build long acyl chains. Each subunit of the ∼ 260 kDa FAS polypeptide is composed of three N-terminal domains [containing the β-ketoacyl synthase (3-oxoacyl synthase), malonyl/acetyltransferase and dehydrase activities] and four C-terminal domains [containing the enoyl reductase, β-ketoacyl reductase (3-oxoacyl reductase), ACP (acyl carrier protein) and thioesterase activities]. (The nomenclature used for the partial activities of fatty acid synthase used in the remainder of the paper is that of [1, 2] ).
During each cycle of fatty acid chain elongation, malonate, covalently bound to ACP through a thioester bond, enters the active site, where acetate or the elongating fatty acid chain is covalently linked to a reactive cysteine residue. In the partial reaction catalysed by β-ketoacyl synthase, the reactive enolate anion, resulting from the decarboxylation of malonate, attacks the acyl-cysteine to form a transient tetrahedral oxyanion, which in turn decomposes rapidly to generate the resting state of β-ketoacyl synthase and the elongated β-ketoacyl (3-oxoacyl) intermediate bound to ACP [2] . Through a consecutive three-step reduction and dehydration catalysed by the β-ketoacyl reductase, β-hydroxyacyl dehydrase and enoyl reductase, the β-ketoacyl moiety is transformed into the saturated derivative. This elongated, saturated acyl derivative then serves as substrate in the next round of chain elongation until the acyl chain is 16 carbons long, a length that is required for optimal activity of the thioesterase that releases the ultimate product, free palmitic acid, from FAS [2] . Several of these partial reactions can be evaluated kinetically, independently of net palmitate synthesis, by use of alternative substrates [1, 2] .
C75 (see Figure 1C ), an inhibitor of FAS [3] , was initially designed to target the crucial condensation step catalysed by the β-ketoacyl synthase. This design was based on the structural similarity of C75, a member of the α-methylene-γ -butyrolactone chemical class, with cerulenin, a well studied FAS inhibitor that specifically targets the β-ketoacyl synthase partial activity. C75 has been suggested as the prototype for at least two aspects of therapeutic utility. First, C75 was proposed as an anti-tumour agent. In two breast cancer cell lines, SKBR3 and MCF7, where FAS was overexpressed, C75 caused apoptosis in a cancer cellspecific manner. Initiation of the apoptotic mechanism was proposed to be caused by the increase in malonyl-CoA levels as a result of FAS inhibition [4] . Secondly, C75 was proposed as an anti-obesity agent. When administered in rodents, C75 had a robust and sustained effect in reducing body weight [5] . Such weight loss effects are attributed to two metabolic consequences of C75 treatment. (1) In the central nervous system, it was hypothesized that C75 raised the malonyl-CoA concentration in the hypothalamus as a result of direct inhibition of FAS enzyme activity [6] , and probably indirectly by inhibition of AMP-activated protein kinase in that region [7, 8] . The elevation of the malonyl-CoA concentration in the hypothalamus, in turn, serves as a second messenger for nutrient status, which mediates appetite suppression [5, 9] . (2) In peripheral tissues, C75 has another effect that is distinct from its action in the central nervous system. C75 acts as a malonyl-CoA analogue that antagonizes the allosteric inhibitory effect of malonyl-CoA on carnitine palmitoyltransferase-1, a rate-controlling enzyme for mitochondrial β-oxidation. As a result, C75 causes a constitutive stimulation of fatty acid β-oxidation in the liver, which also contributes to a robust weight loss effect in rodents [10] .
Although C75 has been shown to inhibit mammalian FAS in a time-dependent manner [3, 11] and has been implicated in the therapeutic areas mentioned above, there have been limited studies characterizing the mechanism of C75-mediated inactivation of FAS at the enzyme level. To fill this void, we report here a detailed characterization of FAS inactivation by C75 through studies of the inhibition of the partial reactions catalysed by FAS and from studies of protection by the substrates.
EXPERIMENTAL

Materials
C75 (purity > 95 % by HPLC) was purchased from Calbiochem (La Jolla, CA, U.S.A.); acetyl-CoA, malonyl-CoA, NADPH, trans-1-decalone, DTT (dithiothreitol), crotonyl-CoA, EDTA disodium salt, cerulenin and palmitic acid were obtained from Sigma (St. Louis, MO, U.S.A.). [1- 14 C]Palmitoyl-CoA was supplied by NEN (Boston, MA, U.S.A.). All other reagents were of analytical grade.
Preparation of rat FAS
Purification of rat liver FAS followed the protocol described by Linn [12] . In the last purification step, Sephacryl 400 (Amersham Biosciences, Piscataway, NJ, U.S.A.) gel filtration chromatography was conducted in buffer A (100 mM potassium phosphate, pH 7.0, 1 mM MgCl 2 , 0.1 mM EDTA, 10% glycerol, 1 mM DTT). SDS/PAGE and subsequent Coomassie Blue staining of the final FAS preparation yielded a single band. During the experiments involving inactivation of FAS by C75, the concentration of DTT was kept below 0.25 mM, a concentration that has no effect on the inactivation of FAS by C75 (Figure 3) . Aliquots of concentrated FAS in buffer A were stored at − 80
• C until use.
Inhibition of the FAS overall reaction
A modification of the method described by Nepokroeff et al. [13] was used to measure the time course of inactivation of the overall reaction. For the inactivation reaction, FAS (0.25 mg/ml; ∼ 0.9 µM active sites; specific activity ∼ 300 nmol/min per mg) and the indicated concentrations of C75 (delivered in DMSO; final concentration 4 %, v/v) and substrates were incubated at room temperature or 37
• C in 0.1 M potassium phosphate buffer, pH 7.0. Inactivation reactions were initiated at time zero by the simultaneous addition of aliquots of FAS. At different time points, 4 µl aliquots of the inactivation reaction mixtures were removed with a multi-channel pipette and diluted 1:50 (v/v) into duplicate wells of a clear polystyrene 96-well plate containing FAS overall reaction assay mixtures (100 µM NADPH, 60 µM malonyl-CoA and 20 µM acetyl-CoA in 0.1 M potassium phosphate buffer, pH 7.0) pre-equilibrated at room temperature. The release of the NADP + product was followed spectrophotometrically for 10 min at 340 nm with a 96-well plate reader (Molecular Devices, Sunnyvale, CA, U.S.A.). Initial rates were used for the calculations.
Inhibition of FAS β-ketoacyl synthase activity
A modification of the assay described by Katiyar et al. [14] was used to measure the inactivation of the β-ketoacyl synthase reaction catalysed by FAS. This partial reaction monitors the formation of triacetic acid lactone at 283 nm from acetyl-CoA and malonyl-CoA in the absence of NADPH [15] . Although generation of triacetic acid lactone represents only ∼ 1 % of the rate of synthesis of 3-oxobutyryl-CoA [16] , the spectrophotometric assay was chosen for convenience and because detection of 3-oxobutyryl-CoA requires a radioactive chromatographic method, which is less practical for generating the number of data points needed for the detailed kinetic analysis. Due to the low sensitivity of this assay, a cuvette-based spectrophotometer and relatively large amounts of FAS were used. Inactivation reaction mixtures containing FAS (0.21 mg/ml enzyme and less than 50 µM DTT; ∼ 0.8 µM active sites; specific activity ∼ 3 nmol/min per mg) and the indicated concentrations of C75 (delivered in DMSO; final concentration 4 %, v/v) and substrates were incubated at room temperature in 0.1 M potassium phosphate buffer, pH 7.0. At different time points, 18 µl aliquots of the inactivation mixtures were added to 382 µl of β-ketoacyl synthase assay mixtures containing 0.1 M potassium phosphate buffer, pH 7.0, acetyl-CoA (40 µM final) and malonyl-CoA (150 µM final) pre-equilibrated at room temperature in quartz, black, self-masking, 1-cm pathlength cuvettes. The formation of the lactone was monitored at 283 nm for 15 min in a UVIKON-940 spectrophotometer equipped with a multi-cell changer (Kontron Instruments, Basel, Switzerland).
Inhibition of FAS β-ketoacyl reductase activity
FAS β-ketoacyl reductase activity was assayed by adapting the method described by Joshi and Smith [17] to a 96-well-platebased format similar to that described for the overall reaction. Inactivation reactions containing FAS (0.08 mg/ml and < 80 µM DTT; ∼ 0.3 µM active sites; specific activity ∼ 900 nmol/min per mg) and the indicated concentrations of C75 and substrates were incubated at room temperature in 0.1 M potassium phosphate buffer, pH 7.0. At various time points, 7 µl aliquots of the inactivation reaction were diluted 1:30 (v/v) into duplicate columns of a clear polystyrene 96-well plate containing β-ketoacyl reductase assay mixtures (100 µM NADPH and 10 mM trans-1-decalone in 0.1 M potassium phosphate buffer, pH 7.0) pre-equilibrated at room temperature. The release of the NADP + product was followed spectrophotometrically for 10 min at 340 nm with a 96-well plate reader. Initial rates were used for the calculations.
Inhibition of FAS enoyl reductase activity
The method described by Nixon et al. [15] was adapted to a 96-well-plate-based format similar to that described for the overall reaction. Inactivation reactions containing FAS (0.8 mg/ml and < 200 µM DTT; ∼ 3 µM active sites; specific activity ∼ 25 nmol/min per mg) and the indicated concentrations of C75 and substrates were incubated at room temperature in 0.1 M potassium phosphate buffer, pH 7.0. At various time points, 10 µl aliquots of the inactivation reaction were diluted 1:20 (v/v) into duplicate enoyl reductase assay mixtures in a clear polystyrene 96-well plate containing 100 µM NADPH and 50 µM crotonylCoA in 0.1 M potassium phosphate buffer, pH 7.0, pre-equilibrated at room temperature. The release of the NADP + product was followed spectrophotometrically for 10 min at 340 nm with a 96-well plate reader, and initial rates were used for the calculations.
Inhibition of FAS thioesterase activity
FAS thioesterase activity was assayed by measuring the hydrolysis of [1- 14 C]palmitoyl-CoA as described by Stoops and Wakil [18] . Inactivation reactions containing FAS (0.2 mg/ml and < 50 µM DTT; ∼ 0.8 µM active sites; specific activity ∼ 25 nmol/min per mg) and the indicated concentrations of C75 and substrates were incubated at room temperature in 0.1 M potassium phosphate buffer, pH 7.0. At various time points, 100 µl aliquots were delivered to the thioesterase reaction mixture containing 100 mM potassium phosphate and 10 µM [1-
14 C]palmitoyl-CoA (3 Ci/ mol; NEN) in a total volume of 500 µl. After incubation at room temperature for 2 min, the reactions were terminated by the addition of 0.1 ml of 10 % (v/v) H 2 SO 4 . Carrier palmitate (0.62 mg) in ethanol was added and the mixture was extracted three times with 3 ml of pentane. The extracts were pooled and the pentane was evaporated to dryness under N 2 . The residue was redissolved in 0.2 ml of pentane and delivered to 5 ml of scintillation fluid, and radioactivity was counted.
Data analysis
Each inhibition reaction was normalized to a DMSO control [4 % (v/v) final concentration] at each time point under conditions where C75 was in excess over FAS. The data for activity (% of control) against time were fitted to the equation for a single exponential decay (first order) to obtain the observed inactivation rate constant. For substrate protection experiments, the Kitz and Wilson analysis [19] was performed by fitting all of the observed inactivation rates at each substrate and C75 concentration to eqn (1) (see below) for competitive inhibition. For C75 saturation experiments in the absence of substrates, data were fitted to eqn (2) , and for competition with substrates at a single C75 concentration, data were fitted to eqn (3) [20] . In these equations, k obs is the observed first-order rate of enzyme inactivation, k inact is the maximal rate of enzyme inactivation, K I is the dissociation constant for the initial (non-covalent) complex of inhibitor with FAS, [I] is the inactivator concentration, [A] is the concentration of protectant (here the substrates), and K A is the dissociation constant for the protectant.
Graphs and fits of the data to non-linear least-squares equations were obtained using the programs XLfit (ID Business Solutions) add-in to Excel (Microsoft) or GraFit version 5.0 (Erithracus Software Ltd., Horley, Surrey, U.K.).
RESULTS
Inactivation of the FAS overall reaction by C75 is pseudo-first-order and saturable
Inactivation time courses were studied in detail by preincubation of various concentrations of C75 at a fixed concentration of rat liver FAS followed by a large dilution of an aliquot of the FAS/C75 mixture into either FAS overall assay mixtures or various FAS partial reaction mixtures at multiple time intervals. As shown in Figure 1 , the mode of inactivation of the FAS overall reaction by C75 appears to be pseudo-first-order at room temperature and at 37 • C. Plots of log activity remaining (expressed as % of control) against preincubation time were linear. The observed rate constants were obtained from fits of the data for activity (% of control) against time to the equation for a single exponential decay. At 37
• C ( Figure 1B , inset), the observed rate constant appeared to increase linearly with increasing concentration of C75, suggestive of either very weak initial inhibitor complex formation or a bimolecular reaction mechanism. However, at room temperature, over a 16-fold range of C75 concentrations, the concentrationdependence of the inactivation rate began to exhibit saturation, indicative of a weak initial inhibitor complex, but was limited by our ability to assay at higher inhibitor concentrations (inset to Figure 1A ; hyperbolic fit of the observed rate constant against C75 concentration data to eqn 2). The results at room temperature are suggestive of the scheme shown in eqn (4) , where an initial reversible complex is converted to the irreversibly inhibited enzyme:
Another indication of this mechanism is shown in Figure 2 are to eqn (1); double-reciprocal graphs are shown for linear representations of the hyperbolic model.
The results of the theoretical fits are summarized in Table 1 . For C75 at ambient temperature, k inact at saturation was approx. 1 min −1 and the K I for the initial complex formation was • C an apparent second-order rate constant of 0.21 min −1 · mM −1 was obtained from the slope of a linear fit to k obs against C75.
Substrates protect the FAS overall reaction from inactivation by C75 in a competitive manner
The effects of various substrates of FAS upon the rate of inactivation of the overall reaction were tested at multiple concentrations of both the substrates and C75 (Figure 2) . Each of the three substrates, i.e. acetyl-CoA, malonyl-CoA and NADPH, diminished the rate of inactivation by C75 in a concentration-dependent and saturable manner. As a representative example, Figure 2 (A) and the inset show that malonyl-CoA progressively lowered the observed rate of FAS inactivation by 1 mM C75 in a concentration-dependent manner, consistent with direct competition between C75 and malonyl-CoA.
The competitive nature of inactivation by C75 with malonylCoA is further illustrated in Figure 2 Figure 2C ) and NADPH ( Figure 2D ). The results from the fits to eqn (1) are summarized in Table 1 . k inact at saturation and K I for the initial complex formation obtained for each of the three substrates were in close agreement. Also, the apparent dissociation constants (K A ) for each of the protectants are in good agreement with their reported K m values (Table 1) .
High concentrations of DTT interfere with the inactivation of FAS by C75
To investigate potential effects of DTT carried over from the storage buffer on the inactivation of FAS by C75, which may obscure the interpretation of kinetic data, we designed experiments to systematically address the effects of DTT. We found that DTT does prevent inactivation of the overall reaction by 1 mM C75. The dose-response relationship of the interference appears to be steep, with little effect at or below 0.4 mM, but a substantial effect at or above 1 mM (Figure 3) . The apparent DTT effect may be attributed to two potential mechanisms. (1) Since it is known that cerulenin forms a covalent adduct with the active cysteine in the condensing enzyme [1, 2] , C75 may also inactivate FAS by such a covalent interaction. DTT may protect this cysteine from the formation of such an adduct. (2) Alternatively, DTT could react directly with C75 chemically, destroying its ability to inactivate FAS. To differentiate between these two possibilities, we first pretreated 5 mM C75 with 5 mM DTT for 45 min. After 10-fold dilution with FAS and buffer, the observed rate of inactivation by this pretreated C75 was then determined and compared with that by untreated C75. Of note, in the subsequent inactivation reaction following the treatment, the DTT concentration was 0.5 mM, a concentration that was shown to have little effect on the inactivation of FAS by C75 (Figure 3) . Pretreatment of C75 with DTT completely abolished its ability to inactivate FAS. This experiment establishes that high concentrations of DTT interfere with the inactivation of FAS by C75.
Malonyl-CoA and acetyl-CoA protect the FAS β-ketoacyl synthase reaction from inactivation by C75
Inactivation of the β-ketoacyl synthase partial reaction of FAS by C75 was characterized in a manner similar to that for the overall reaction, except that NADPH was not present in the assay (see the Experimental section). Similar to that observed for the overall reaction, inactivation of the β-ketoacyl synthase activity was concentration-dependent, pseudo-first-order, and prevented by both acetyl-CoA and malonyl-CoA (Figure 4 ). Since carry-over of even a small amount of NADPH from the preincubation mixture interfered with this assay for monitoring the β-ketoacyl synthase partial activity, the protectant effects of this substrate were not studied.
The observed rates of inactivation of the β-ketoacyl synthase were about 1.5 times higher than those observed for the overall reaction at the same concentrations of C75 (Table 2) . At the same concentrations of either acetyl-CoA or malonyl-CoA, the protection, measured by the relative k inact at 1 mM C75, was about 2-fold lower for the β-ketoacyl synthase than for the overall reaction (Table 2) . From the fits of the data to eqn (3), as shown in the insets to Figures 4(B) and 4(C), it appears that both acetylCoA and malonyl-CoA protect the β-ketoacyl synthase activity of FAS from inactivation by C75 in a competitive manner. The dissociation constants obtained for these two protectants from fits of the data to eqn (3) were 2.8 µM for acetyl-CoA and 4.5 µM for malonyl-CoA, in good agreement with the values obtained for the overall reaction (Table 1) .
Inactivation by C75 of the FAS β-ketoacyl reductase reaction is not a simple first-order process and is not reversed by acetyl-CoA
Preincubation/dilution was also used to characterize the inactivation of the β-ketoacyl reductase partial activity of FAS by C75. Unlike the overall reaction or the other partial reactions studied, there was a lag before the C75-mediated inactivation of the β-ketoacyl reductase by an apparent pseudo-first-order process (Figure 5) . The extent of the lag was inversely dependent on the concentration of C75: at 1 mM C75, the lag period extended to nearly 1 h before the loss of β-ketoacyl reductase activity was observed; at 2 mM C75 the lag was reduced to about 20 min; and at 4 mM C75 the lag was reduced further to < 5 min ( Figure 5 ). No loss of β-ketoacyl reductase activity was observed at 0.5 mM C75 with up to 120 min of preincubation.
We do not yet understand the origin of the lag observed when monitoring this partial reaction. However, inactivation of the β-ketoacyl reductase activity at 4 mM C75 was pseudo-first-order, and the observed k inact was 0.056 min −1 , approx. 3.4 times slower than the observed k inact for the overall reaction at 4 mM C75 (0.19 min −1 ). At a lower concentration of C75 in the preincubation (1 mM), neither the lag period nor the rate of inactivation was affected by acetyl-CoA (Table 2) . At 100 µM NADPH and 1 mM C75, the lag period was > 120 min, and no inactivation was observed up to that time point, indicating that NADPH was either preventing or delaying further the onset of inactivation by C75 (Table 2) . Malonyl-CoA interfered with the β-ketoacyl reductase assay and could not be studied as a protectant.
Substrates protect the FAS enoyl reductase reaction from inactivation by C75
Inactivation by C75 of the enoyl reduction catalysed by FAS was probed using crotonyl-CoA instead of malonyl-CoA and acetylCoA in the assay post-preincubation. As observed for the overall reaction and the β-ketoacyl synthase partial reaction, C75-mediated inactivation of enoyl reduction was concentration-dependent, followed pseudo-first-order kinetics and was prevented by all three substrates, i.e. NADPH, acetyl-CoA and malonyl-CoA (Figure 6 ). Unlike the unusual inactivation kinetics of the β-ketoacyl reductase activity, no lag periods were observed for the inactivation of the enoyl reductase by C75. The observed k inact values were comparable with those for the β-ketoacyl synthase at the same C75 concentrations and about 1.5 times higher than the inactivation rates for the overall reaction (Table 2) . Also, similar to the results with the β-ketoacyl synthase activity, at the same concentrations of acetyl-CoA and malonyl-CoA, relatively less protection was observed for the enoyl reductase than for the overall reaction, while 100 µM NADPH afforded about the same protection for both reactions (Table 2 ). Protection by acetyl-CoA, malonyl-CoA and NADPH also appeared to be concentrationdependent and competitive with C75 for the enoyl reductase partial reaction (Figure 6 , insets). Dissociation constants obtained for these three protectants from fits of the data to eqn (3) were 1.2 µM for acetyl-CoA, 4.9 µM for malonyl-CoA and 6.4 µM for NADPH, in good agreement with the values obtained for the overall reaction (Table 1 ) and the β-ketoacyl synthase activity (see above).
Substrates do not protect the FAS thioesterase reaction from inactivation by C75
The thioesterase activity of FAS was monitored using a radiochemical assay. As shown in Figure 7 and Table 2 , inactivation of the thioesterase was pseudo-first-order at 1 mM C75, and the observed rate of inactivation was 0.13 min −1 , i.e. 2.4 times faster than inactivation of the overall reaction and about 1.6 times faster than inactivation of the β-ketoacyl synthase and the enoyl reductase activities at the same concentration of C75. In sharp contrast with the overall reaction, the β-ketoacyl synthase reaction and the enoyl reductase reaction, acetyl-CoA, malonyl-CoA and NADPH did not protect the thioesterase from inactivation by C75.
DISCUSSION
The experiments described here were conducted in order to clarify the detailed mechanism of inhibition of mammalian FAS by C75. The rat liver enzyme was inactivated by C75 in a concentration-dependent manner which obeyed pseudo-firstorder kinetics. Inactivation kinetics were saturable, but relatively inefficient, with a k inact at saturation of 1 min −1 and a K I for initial complex formation of approx. 16 mM. The apparent secondorder rate constants of 0.06 mM −1 · min −1 calculated from these values at room temperature and of 0.21 mM −1 · min −1 at 37 • C calculated from the slope of k obs against [C75] are similar in magnitude to the value reported for iodoacetamide of 0.19 mM −1 · min −1 with chicken liver FAS at 25
• C [18] , but are considerably lower than those of the well-studied, specific FAS inactivator cerulenin (5.8 mM −1 · min −1 for yeast FAS at 0 • C) [21] , and the reported value for C75-mediated inactivation of chicken liver FAS at 37
• C (1.3 min −1 · mM −1 ) [11] . In our own experiments, we observed that 1 mM cerulenin inactivated rat liver FAS activity completely within 30 s at room temperature (results not shown). This rapid inactivation of rat FAS by cerulenin is consistent with the large difference between the kinetic parameters for C75 with mammalian FAS and those reported for cerulenin at lower temperatures with yeast FAS. The present study represents the first detailed report of the effects of C75 on various partial reactions catalysed by FAS. Although we provide experimental evidence that C75 inactivates the β-ketoacyl synthase activity, as long speculated in the literature [3] , to our surprise C75 also exhibited clear inactivation of other partial activities, such as the enoyl reductase and the thioesterase. Of note, the relative k inact values for these three partial activities were similar to each other and about the same or higher than that of the overall reaction. Therefore, if the inactivation of these partial activities is independent, then inactivation of any one of these activities could contribute significantly to inactivation of the overall reaction. In contrast, the onset of inactivation of the β-ketoacyl reductase was delayed and much slower than inactivation of the overall reaction, indicative of an inactivation mechanism that may not involve the normal functions of the enzyme. This feature of inactivation of multiple partial activities of FAS by C75 is in sharp contrast with the effects of cerulenin, which was shown to inactivate only the β-ketoacyl synthase [21, 22] .
The differences between cerulenin and C75 were highlighted further in substrate protection experiments. Protection from inactivation by C75 was afforded by both acetyl-CoA and malonylCoA for the overall reaction and the β-ketoacyl synthase and enoyl reductase partial reactions, but not for the thioesterase activity. However, only the β-ketoacyl synthase is inactivated by cerulenin, with protection by only acetyl-CoA and not malonyl-CoA [21] . Also in contrast with inactivation by cerulenin, NADPH protected the overall reaction and the enoyl reductase from inactivation by C75.
With respect to the overall FAS reaction, C75 is a competitive irreversible inhibitor with regard to all three substrates, with the kinetics of the complexing type, i.e. a weak non-covalent enzyme-inhibitor complex is formed before irreversible enzyme modification. In addition, protection of the β-ketoacyl synthase and enoyl reductase activities by malonyl-CoA and acetyl-CoA appears to be competitive with C75, as does NADPH protection of the enoyl reductase activity. Although the differences could be due to a large temperature or species effect or both, the protection results with rat liver FAS and C75 at ambient temperatures differ from those reported by Wang and Tian [11] for chicken liver FAS at 37
• C. With chicken liver FAS, the overall reaction was protected from C75-mediated inactivation by malonyl-CoA, but not significantly by acetyl-CoA or NADPH [11] . Also, in contrast with the saturation shown here at room temperature, but similar to our observations at 37
• C, Wang and Tian [11] observed a linear relationship between the observed k inact and the concentration of C75 at 37
• C, perhaps because K I was elevated at the higher temperature to an extent not detected in their experiments. Finally, they also observed biphasic inactivation kinetics at the higher temperature, with the slower phase having an apparent second-order rate constant (∼ 0.13 mM −1 · min −1 ) much closer to the value for rat liver FAS (∼ 0.21 mM −1 · min −1 at 37 • C and 0.06 mM −1 · min −1 at room temperature). Both differences may be explained by the different experimental temperatures [20] .
The lower inactivation rates and delay in the onset of inactivation for the β-ketoacyl reductase activity could be due to nonspecific and/or non-active-site-directed effects of C75, in contrast with its effects on the β-ketoacyl synthase, enoyl reductase or overall reactions. Partitioning of the initial reversible EI complex between inactive enzyme and a slowly interconverting, reversible conformation (FI) that cannot directly form inactive enzyme could explain the lag prior to the inactivation of the β-ketoacyl reductase (eqn 5):
In this mechanism, FI is either a very weakly inhibitory complex or a non-inhibitory complex, such that dilution into the β-ketoacyl reductase assay results in full activity. Alternatively, FI could reversibly release and recombine with C75 during the preincubation. It is also interesting to note that the β-ketoacyl reductase assay does not use a substrate with a CoA thioester, which may explain the unusual kinetics for C75-mediated inactivation. C75 may interfere more rapidly with either the cysteine or ACP thiol groups involved in thioester exchange with the CoA substrates, but not immediately affect the reduction of transdecalone. Much slower interaction with a different enzyme nucleophile may account for the slower C75-mediated inactivation kinetics for the β-ketoacyl reductase. Consistent with these findings, Wang and Tian [11] did not observe inactivation of chicken liver β-ketoacyl reduction using a different substrate, ethyl acetoacetate, which also lacked a CoA thioester.
We also observed that, at concentrations of 1 mM, DTT blocked the inactivation of rat FAS by C75, but this is most probably due to a reaction in solution to form an ineffective DTT-C75 adduct. This feature of C75 is another difference from cerulenin, in that DTT, cysteine and 2-mercaptoethanol did not protect yeast FAS from inactivation by cerulenin [21] . One potential consequence of the apparent reactivity of C75 with nucleophiles in solution is that its efficacy in vivo may be diminished by reaction with endogenous thiols such as glutathione.
The present study is also the first report on the inactivation of the thioesterase activity of a mammalian FAS by C75. The inability of malonyl-CoA to protect the thioesterase activity from inactivation by C75 implies that the mechanism of inactivation may be very different from that for the β-ketoacyl synthase or the enoyl reductase activities. It is difficult to explain all the observed effects of C75 by postulating a single site of interaction. However, additional studies are needed to fully elucidate whether C75 has a single site of action resulting in multiple effects on the partial activities of FAS, or has multiple sites of action with similar inactivation kinetics leading to the different effects on FAS reactions.
The specific activities of the rat FAS preparation used in the present study were lower than the best values reported in the literature, when assessed either for the overall reaction or for the various partial activities [12, 23] . These discrepancies could be due to different methods for measuring protein concentration, or to different assay temperatures (ambient temperature was employed for the present study), or to the possibility that the assay conditions were not optimized for maximal velocity at room temperature. However, the relative order of the activities, i.e. β-ketoacyl reductase (∼ 900 nmol/min per mg) > overall reaction (∼ 300 nmol/min per mg) > thioesterase (∼ 25 nmol/min per mg) = enoyl reductase (∼ 25 nmol/min per mg) > β-ketoacyl synthase (∼ 3 nmol/min per mg), was the same as that observed for chicken liver FAS [18] and for human FAS [24] . Also, because the rates of C75-mediated inactivation of the β-ketoacyl synthase, enoyl reductase and thioesterase partial activities are comparable with that for the overall reaction, we believe that the conclusions from the current work are valid.
FAS has been discussed as a potential target for anti-obesity intervention therapy [5] . However, the relatively weak ability of C75 to inactivate FAS as reported in the present paper raises questions about the relevance in vivo of inhibition of FAS by C75. In addition to inhibition of FAS, C75 has been shown to have a variety of biological activities, including activation of carnitine palmitoyltransferase-1, which is a rate-limiting enzyme for β-oxidation [10] . C75 has also been shown to decrease AMP-activated protein kinase activity in the brain [7, 8] , which may conceivably result in an anorectic effect [25] . These biological activities of C75 offer alternative explanations to inhibition of FAS for the robust weight loss effect elicited by C75 [5] . Recent studies of the pharmacokinetic features of C75 and comparisons of the anorectic level of C75 in vivo with the potency of FAS inhibition in vitro provide support for the alternative explanations [26] .
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